These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 33472858)

  • 1. Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β.
    Brownlie D; Doughty-Shenton D; Yh Soong D; Nixon C; O Carragher N; M Carlin L; Kitamura T
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33472858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The breast tumor microenvironment alters the phenotype and function of natural killer cells.
    Krneta T; Gillgrass A; Chew M; Ashkar AA
    Cell Mol Immunol; 2016 Sep; 13(5):628-39. PubMed ID: 26277898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
    Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
    Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
    Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL
    Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
    Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
    J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocytes Differentiate to Immune Suppressive Precursors of Metastasis-Associated Macrophages in Mouse Models of Metastatic Breast Cancer.
    Kitamura T; Doughty-Shenton D; Cassetta L; Fragkogianni S; Brownlie D; Kato Y; Carragher N; Pollard JW
    Front Immunol; 2017; 8():2004. PubMed ID: 29387063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural cytotoxicity receptor 1 contribution to early clearance of Streptococcus pneumoniae and to natural killer-macrophage cross talk.
    Elhaik-Goldman S; Kafka D; Yossef R; Hadad U; Elkabets M; Vallon-Eberhard A; Hulihel L; Jung S; Ghadially H; Braiman A; Apte RN; Mandelboim O; Dagan R; Mizrachi-Nebenzahl Y; Porgador A
    PLoS One; 2011; 6(8):e23472. PubMed ID: 21887255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity.
    Bernard PL; Delconte R; Pastor S; Laletin V; Costa Da Silva C; Goubard A; Josselin E; Castellano R; Krug A; Vernerey J; Devillier R; Olive D; Verhoeyen E; Vivier E; Huntington ND; Nunes J; Guittard G
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35589278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupting Smad3 potentiates immunostimulatory function of NK cells against lung carcinoma by promoting GM-CSF production.
    Lian GY; Wang QM; Mak TS; Huang XR; Yu XQ; Lan HY
    Cell Mol Life Sci; 2024 Jun; 81(1):262. PubMed ID: 38878186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer.
    Smyth MJ; Teng MW; Swann J; Kyparissoudis K; Godfrey DI; Hayakawa Y
    J Immunol; 2006 Feb; 176(3):1582-7. PubMed ID: 16424187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.
    Spallanzani RG; Dalotto-Moreno T; Raffo Iraolagoitia XL; Ziblat A; Domaica CI; Avila DE; Rossi LE; Fuertes MB; Battistone MA; Rabinovich GA; Salatino M; Zwirner NW
    Cancer Immunol Immunother; 2013 Dec; 62(12):1781-95. PubMed ID: 24114144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
    Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
    Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses.
    Salagianni M; Lekka E; Moustaki A; Iliopoulou EG; Baxevanis CN; Papamichail M; Perez SA
    J Immunol; 2011 Mar; 186(6):3327-35. PubMed ID: 21317394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF.
    Kitamura T; Kato Y; Brownlie D; Soong DYH; Sugano G; Kippen N; Li J; Doughty-Shenton D; Carragher N; Pollard JW
    Cancer Immunol Res; 2019 Dec; 7(12):2052-2064. PubMed ID: 31615815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.
    Lakshmikanth T; Burke S; Ali TH; Kimpfler S; Ursini F; Ruggeri L; Capanni M; Umansky V; Paschen A; Sucker A; Pende D; Groh V; Biassoni R; Höglund P; Kato M; Shibuya K; Schadendorf D; Anichini A; Ferrone S; Velardi A; Kärre K; Shibuya A; Carbone E; Colucci F
    J Clin Invest; 2009 May; 119(5):1251-63. PubMed ID: 19349689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
    In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asiaticoside modulates human NK cell functional fate by mediating metabolic flexibility in the tumor microenvironment.
    Guo Y; Xu J; Jia Y; Tian Y; Zhang Y; Zhang J; Wang Y; Chen L
    Phytomedicine; 2024 Oct; 133():155921. PubMed ID: 39121533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection.
    Diab M; Glasner A; Isaacson B; Bar-On Y; Drori Y; Yamin R; Duev-Cohen A; Danziger O; Zamostiano R; Mandelboim M; Jonjic S; Bacharach E; Mandelboim O
    Eur J Immunol; 2017 Apr; 47(4):692-703. PubMed ID: 28191644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model.
    Gillgrass AE; Chew MV; Krneta T; Ashkar AA
    BMC Cancer; 2015 Apr; 15():293. PubMed ID: 25879689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.